ONL1204 Ophthalmic Solution

· ONL Therapeutics

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for ONL1204 Ophthalmic Solution, covering 2024-02-29 to 2024-11-19. Get the full timeline:

Most recent: Clinical Trial Update: ONL1204 Ophthalmic Solution in Patients With Geographic Atrophy Associated With Age-related Macular Degeneration [Phase 1]

See pricing